日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex

在德国真实世界环境中，Tivozanib一线治疗转移性肾细胞癌的疗效：前瞻性、非干预性、上市后研究T-Rex的结果

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17243910
Grünwald, Viktor; Rußwurm, Karen; Eckert, Ralf; Seseke, Sandra; Standhaft, Diana; Hegemann, Miriam; Baumann, Steffen; Brenneis, Horst; Seidel, Michael; Rau, Olrik; Schirrmacher-Memmel, Silke; Hellmis, Eva; Fieseler, Claus F; Doehn, Christian; Ziske, Carsten; Distelrath, Andrea; Marschner, Norbert; Ivanyi, Philipp; Herold, Martin; Loehr, Bianca I; Lange, Carsten; Janitzky, Andreas; Bögemann, Martin
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study

在德国、奥地利和瑞士，奈拉替尼作为HER2阳性/HR阳性早期乳腺癌患者的延长辅助治疗：前瞻性观察性ELEANOR研究的中期结果

期刊:Breast Care
影响因子:2.1
doi:10.1159/000533657
Harbeck, Nadia; Wrobel, Denise; Zaiss, Matthias; Terhaag, Jürgen; Guth, Dagmar; Distelrath, Andrea; Zahn, Mark-Oliver; Wuerstlein, Rachel; Lorenz, Andreas; Bartsch, Rupert; Breitenstein, Urs; Schwitter, Michael; Balic, Marija; Jackisch, Christian; Müller, Volkmar; Rinnerthaler, Gabriel; Schmidt, Marcus; Zaman, Khalil; Schinköthe, Timo; Resch, Anna; Valenti, Roberta; Lüftner, Diana
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial

依维莫司联合依西美坦治疗激素受体阳性、人表皮生长因子受体2阴性的绝经后局部晚期或转移性乳腺癌患者的疗效和安全性：单臂IIIB期4EVER试验结果

期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.31738
Tesch, Hans; Stoetzer, Oliver; Decker, Thomas; Kurbacher, Christian M; Marmé, Frederik; Schneeweiss, Andreas; Mundhenke, Christoph; Distelrath, Andrea; Fasching, Peter A; Lux, Michael P; Lüftner, Diana; Hadji, Peyman; Janni, Wolfgang; Muth, Mathias; Kreuzeder, Julia; Quiering, Claudia; Taran, Florin-Andrei
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2019
文献求助 收藏

The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trial

在 IIIb 期 4EVER 试验中，哺乳动物雷帕霉素靶蛋白抑制剂对接受依维莫司联合依西美坦治疗的激素受体阳性绝经后晚期乳腺癌女性骨骼健康的影响

期刊:Journal of Bone Oncology
影响因子:3.5
doi:10.1016/j.jbo.2018.09.010
Hadji, Peyman; Stoetzer, Oliver; Decker, Thomas; Kurbacher, Christian M; Marmé, Frederik; Schneeweiss, Andreas; Mundhenke, Christoph; Distelrath, Andrea; Fasching, Peter A; Lux, Michael P; Lüftner, Diana; Janni, Wolfgang; Muth, Mathias; Kreuzeder, Julia; Quiering, Claudia; Grischke, Eva-Marie; Tesch, Hans
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2019
文献求助 收藏

Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis

对 35 例携带四种不同 MPLW515 突变且患有原发性血小板增多症或原发性骨髓纤维化的新病例进行特征分析

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.13224
Schnittger, Susanne; Bacher, Ulrike; Haferlach, Claudia; Beelen, Dietrich; Bojko, Peter; Bürkle, Dieter; Dengler, Robert; Distelrath, Andrea; Eckart, Michael; Eckert, Robert; Fries, Stefan; Knoblich, Jan; Köchling, Georg; Laubenstein, Hans-Peter; Petrides, Petro; Planker, Manfred; Pihusch, Rudolf; Weide, Rudolf; Kern, Wolfgang; Haferlach, Torsten
血小板
MPL
发表日期：2009
文献求助 收藏